Dexamethasone
(right click,save link as to download,it is a temp file,please download as soon as possible, you can also use CTRL+S to save the whole html page)
Basic Info
| Common Name | Dexamethasone(F06148) |
| 2D Structure | |
| FRCD ID | F06148 |
| CAS Number | 50-02-2 |
| PubChem CID | 5743 |
| Formula | C22H29FO5 |
| IUPAC Name | (8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one |
| InChI Key | UREBDLICKHMUKA-CXSFZGCWSA-N |
| InChI | InChI=1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15+,16+,17+,19+,20+,21+,22+/m1/s1 |
| Canonical SMILES | CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C |
| Isomeric SMILES | C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)CO)O)C)O)F)C |
| Synonyms |
Decadron
Hexadecadrol
dexamethasone
50-02-2
Dexamethazone
Maxidex
Decaspray
Desametasone
Dexacort
Dexasone
|
| Classifies |
Veterinary Drug
|
| Update Date | Nov 13, 2018 17:07 |
Chemical Taxonomy
| Kingdom | Organic compounds |
| Superclass | Lipids and lipid-like molecules |
| Class | Steroids and steroid derivatives |
| Subclass | Hydroxysteroids |
| Intermediate Tree Nodes | Not available |
| Direct Parent | 21-hydroxysteroids |
| Alternative Parents |
|
| Molecular Framework | Aliphatic homopolycyclic compounds |
| Substituents | Progestogin-skeleton - 21-hydroxysteroid - Pregnane-skeleton - 20-oxosteroid - 3-oxo-delta-1,4-steroid - 3-oxosteroid - 17-hydroxysteroid - 11-hydroxysteroid - 11-beta-hydroxysteroid - 9-halo-steroid - Halo-steroid - Oxosteroid - Delta-1,4-steroid - Alpha-hydroxy ketone - Cyclic alcohol - Tertiary alcohol - Ketone - Fluorohydrin - Halohydrin - Secondary alcohol - Cyclic ketone - Organooxygen compound - Alcohol - Primary alcohol - Hydrocarbon derivative - Organic oxide - Carbonyl group - Organic oxygen compound - Alkyl halide - Alkyl fluoride - Organohalogen compound - Organofluoride - Aliphatic homopolycyclic compound |
| Description | This compound belongs to the class of organic compounds known as 21-hydroxysteroids. These are steroids carrying a hydroxyl group at the 21-position of the steroid backbone. |
Properties
| Property Name | Property Value |
|---|---|
| Molecular Weight | 392.467 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 2 |
| Complexity | 805 |
| Monoisotopic Mass | 392.2 |
| Exact Mass | 392.2 |
| XLogP | 1.9 |
| Formal Charge | 0 |
| Heavy Atom Count | 28 |
| Defined Atom Stereocenter Count | 8 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Isotope Atom Count | 0 |
| Covalently-Bonded Unit Count | 1 |
ADMET
| Model | Result | Probability |
|---|---|---|
| Absorption | ||
| Blood-Brain Barrier | BBB+ | 0.9781 |
| Human Intestinal Absorption | HIA+ | 0.9920 |
| Caco-2 Permeability | Caco2+ | 0.8304 |
| P-glycoprotein Substrate | Substrate | 0.7862 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.8112 |
| Non-inhibitor | 0.8134 | |
| Renal Organic Cation Transporter | Non-inhibitor | 0.7971 |
| Distribution | ||
| Subcellular localization | Mitochondria | 0.8255 |
| Metabolism | ||
| CYP450 2C9 Substrate | Non-substrate | 0.8733 |
| CYP450 2D6 Substrate | Non-substrate | 0.9115 |
| CYP450 3A4 Substrate | Substrate | 0.7315 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9380 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9106 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9231 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9247 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8308 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9169 |
| Excretion | ||
| Toxicity | ||
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9558 |
| Inhibitor | 0.5091 | |
| AMES Toxicity | Non AMES toxic | 0.9132 |
| Carcinogens | Non-carcinogens | 0.9399 |
| Fish Toxicity | High FHMT | 0.9926 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9983 |
| Honey Bee Toxicity | High HBT | 0.7746 |
| Biodegradation | Not ready biodegradable | 1.0000 |
| Acute Oral Toxicity | III | 0.8328 |
| Carcinogenicity (Three-class) | Non-required | 0.7364 |
| Model | Value | Unit |
|---|---|---|
| Absorption | ||
| Aqueous solubility | -3.7026 | LogS |
| Caco-2 Permeability | 1.0834 | LogPapp, cm/s |
| Distribution | ||
| Metabolism | ||
| Excretion | ||
| Toxicity | ||
| Rat Acute Toxicity | 2.1482 | LD50, mol/kg |
| Fish Toxicity | 0.8318 | pLC50, mg/L |
| Tetrahymena Pyriformis Toxicity | 1.0232 | pIGC50, ug/L |
MRLs
| Food | Product Code | Country | MRLs | Application Date | Notes |
|---|---|---|---|---|---|
| Honey | Japan | 0. residue was detected | |||
| Other Aquatic Animal | Japan | 0. residue was detected | |||
| Crustaceans | Japan | 0. residue was detected | |||
| Shelled Molluscas | Japan | 0. residue was detected | |||
| Other Fish | Japan | 0. residue was detected | |||
| Perciformes | Japan | 0. residue was detected | |||
| Anguilliformes | Japan | 0. residue was detected | |||
| Salmoniformes | Japan | 0. residue was detected | |||
| Other Poultry,Eggs | Japan | 0. residue was detected | |||
| Chicken,Eggs | Japan | 0. residue was detected | |||
| Other Poultry Animals,Edible Offal | Japan | 0.01ppm | |||
| Chicken,Edible Offal | Japan | 0.01ppm | |||
| Other Poultry Animals,Kidney | Japan | 0.01ppm | |||
| Chicken,Kidney | Japan | 0.01ppm | |||
| Chicken,Liver | Japan | 0.01ppm | |||
| Other Poultry Animals,Fat | Japan | 0.01ppm | |||
| Chicken,Fat | Japan | 0.01ppm | |||
| Other Poultry Animals,Muscle | Japan | 0.01ppm | |||
| Chicken,Muscle | Japan | 0.01ppm | |||
| Milk | Japan | 0.02ppm |
References
| Title | Journal | Date | Pubmed ID |
|---|---|---|---|
| Antioxidant, anti-inflammatory, and enzyme inhibitory activity of natural plant flavonoids and their synthesized derivatives. | J Biochem Mol Toxicol | 2018 Jan | 28972678 |
| [Adverse reaction to food additives in a pediatric patient]. | Rev Alerg Mex | 2018 Apr-Jun | 29983016 |
| Compound edaravone alleviates lipopolysaccharide (LPS)-induced acute lung injury in mice. | Eur J Pharmacol | 2017 Sep 15 | 28552343 |
| Molecular Integration of Incretin and Glucocorticoid Action ReversesImmunometabolic Dysfunction and Obesity. | Cell Metab | 2017 Oct 3 | 28943448 |
| Opuntia humifusa modulates morphological changes characteristic of asthma viaIL-4 and IL-13 in an asthma murine model. | Food Nutr Res | 2017 Oct 24 | 29151835 |
| FDA Drug Approval: Elotuzumab in Combination with Lenalidomide and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma. | Clin Cancer Res | 2017 Nov 15 | 28249893 |
| FDA Approval Summary: Daratumumab for Treatment of Multiple Myeloma After OnePrior Therapy. | Oncologist | 2017 Nov | 28904172 |
| In vitro and in silico assessment of the structure-dependent binding of bisphenol analogues to glucocorticoid receptor. | Anal Bioanal Chem | 2017 Mar | 28078411 |
| Long-Term Dexamethasone Exposure Down-Regulates Hepatic TFR1 and Reduces LiverIron Concentration in Rats. | Nutrients | 2017 Jun 17 | 28629118 |
| Glucose homeostasis in rats treated with 4-vinylcyclohexene diepoxide is notworsened by dexamethasone treatment. | J Steroid Biochem Mol Biol | 2017 Jan | 27264932 |
| Proteasome inhibitors in AL amyloidosis: focus on mechanism of action and clinical activity. | Hematol Oncol | 2017 Dec | 27647123 |
| Co-administration of walnut (Juglans regia) prevents systemic hypertensioninduced by long-term use of dexamethasone: a promising strategy for steroidconsumers. | Pharm Biol | 2017 Dec | 27653214 |
| Upper and lower respiratory tract microbiota in horses: bacterial communitiesassociated with health and mild asthma (inflammatory airway disease) and effects of dexamethasone. | BMC Microbiol | 2017 Aug 23 | 28835202 |
| Anti-inflammatory effects of physalin E from Physalis angulata on lipopolysaccharide-stimulated RAW 264.7 cells through inhibition of NF-κB pathway. | Immunopharmacol Immunotoxicol | 2017 Apr | 28152630 |
| Dietary 2-oxoglutarate prevents bone loss caused by neonatal treatment withmaximal dexamethasone dose. | Exp Biol Med (Maywood) | 2017 Apr | 28178857 |
| Dexamethasone-induced hepatomegaly and steatosis in larval zebrafish. | J Toxicol Sci | 2017 | 28717104 |
| Anti-inflammatory effects of Salvia plebeia R. Br extract in vitro and in ovalbumin-induced mouse model. | Biol Res | 2016 Oct 5 | 27716424 |
| Dexamethasone reverses the effects of high glucose on human retinal endothelialcell permeability and proliferation in vitro. | Exp Eye Res | 2016 Oct | 27523466 |
| Natural product HTP screening for antibacterial (E.coli 0157:H7) and anti-inflammatory agents in (LPS from E. coli O111:B4) activated macrophages and microglial cells; focus on sepsis. | BMC Complement Altern Med | 2016 Nov 15 | 27846826 |
| Activation of inflammatory immune gene cascades by lipopolysaccharide (LPS) in the porcine colonic tissue ex-vivo model. | Clin Exp Immunol | 2016 Nov | 27406528 |